Qiuming Zeng

785 total citations
41 papers, 406 citations indexed

About

Qiuming Zeng is a scholar working on Neurology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Qiuming Zeng has authored 41 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 13 papers in Immunology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Qiuming Zeng's work include Peripheral Neuropathies and Disorders (11 papers), Multiple Sclerosis Research Studies (11 papers) and Myasthenia Gravis and Thymoma (6 papers). Qiuming Zeng is often cited by papers focused on Peripheral Neuropathies and Disorders (11 papers), Multiple Sclerosis Research Studies (11 papers) and Myasthenia Gravis and Thymoma (6 papers). Qiuming Zeng collaborates with scholars based in China, United States and Australia. Qiuming Zeng's co-authors include Huan Yang, Yue‐Bei Luo, Ran Zhou, Song Ouyang, Zhaohui Luo, Bo Hu, Huan Yang, Rong Tang, Wallace Y. Langdon and Xiaohua Dong and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Scientific Reports.

In The Last Decade

Qiuming Zeng

33 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiuming Zeng China 10 142 121 75 74 67 41 406
Kimitoshi Kimura Japan 8 278 2.0× 114 0.9× 57 0.8× 48 0.6× 86 1.3× 14 468
Truong‐Minh Dang Singapore 6 152 1.1× 205 1.7× 23 0.3× 34 0.5× 66 1.0× 6 437
Na Yao China 13 212 1.5× 56 0.5× 49 0.7× 81 1.1× 57 0.9× 39 458
Ning‐Yuan Chen United States 11 193 1.4× 157 1.3× 28 0.4× 31 0.4× 28 0.4× 14 646
Maria Stensland Norway 12 178 1.3× 91 0.8× 21 0.3× 29 0.4× 24 0.4× 30 438
Catherine Dowling United States 9 102 0.7× 151 1.2× 44 0.6× 43 0.6× 192 2.9× 14 388
Amin Daei Sorkhabi Iran 10 92 0.6× 118 1.0× 36 0.5× 49 0.7× 18 0.3× 22 374
Maria Dobre Romania 13 182 1.3× 77 0.6× 14 0.2× 40 0.5× 80 1.2× 52 496
Sarah Williams United Kingdom 10 210 1.5× 53 0.4× 33 0.4× 49 0.7× 36 0.5× 20 445
Chiara Baiguera Italy 8 55 0.4× 39 0.3× 94 1.3× 102 1.4× 47 0.7× 22 450

Countries citing papers authored by Qiuming Zeng

Since Specialization
Citations

This map shows the geographic impact of Qiuming Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuming Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuming Zeng more than expected).

Fields of papers citing papers by Qiuming Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuming Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuming Zeng. The network helps show where Qiuming Zeng may publish in the future.

Co-authorship network of co-authors of Qiuming Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuming Zeng. A scholar is included among the top collaborators of Qiuming Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuming Zeng. Qiuming Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yumin, Wei Luo, Qiuyue Wang, et al.. (2025). Anion gap predicting 90-Day mortality and guiding furosemide use in ARDS. Scientific Reports. 15(1). 4954–4954. 2 indexed citations
2.
Cao, Yongliang, Yifei Xu, Meiqun Cao, et al.. (2025). Fluid-based biomarkers for neurodegenerative diseases. Ageing Research Reviews. 108. 102739–102739. 9 indexed citations
3.
Duan, Tianjiao, et al.. (2025). Clinical Analysis of MOG Antibody‐Associated Disease Overlapped With Anti‐NMDA Receptor Encephalitis: A Long‐Term Retrospective Study. European Journal of Neuroscience. 61(1). e16654–e16654. 1 indexed citations
4.
Li, Wenying, et al.. (2024). Novel Hypoxia-related Biomarkers and Targeted Drugs for Acute Myocardial Infarction Revealed by Bioinformatics. Letters in Drug Design & Discovery. 21(18). 4529–4543.
5.
Chen, Jinxin, et al.. (2024). Tailoring Morphology of MgO with Mg-MOF for the Enhanced Adsorption of Congo Red. ACS Omega. 9(40). 41676–41686. 7 indexed citations
6.
Wang, Pengfei, et al.. (2024). Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis. Journal of Neuroinflammation. 21(1). 28–28. 16 indexed citations
7.
Jiang, Fei, Hongliang Li, Song Ouyang, et al.. (2024). Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study. Annals of Clinical and Translational Neurology. 11(10). 2769–2784.
8.
Liu, Yu, Xiaohua Dong, Fei Jiang, et al.. (2023). Analysis of LAP+ and GARP+ Treg subsets in peripheral blood of patients with neuromyelitis optica spectrum disorders. Neurological Sciences. 44(5). 1739–1747. 5 indexed citations
9.
Wang, Yuge, Xiaonan Zhong, Honghao Wang, et al.. (2022). Batoclimab as an add‐on therapy in neuromyelitis optica spectrum disorder patients with acute attacks. European Journal of Neurology. 30(1). 195–203. 13 indexed citations
10.
Zhou, Ran, et al.. (2021). Vaccination in neuromyelitis optica spectrum disorders: Friend or enemy?. Multiple Sclerosis and Related Disorders. 58. 103394–103394. 8 indexed citations
11.
Zhou, Ran, Hongliang Li, Huan Yang, et al.. (2021). Serological markers exploration and real-world effectiveness and safety of teriflunomide in south Chinese patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 58. 103446–103446. 7 indexed citations
12.
Zhou, Ran, et al.. (2021). Case Report: Antibodies to the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis. Frontiers in Immunology. 12. 664364–664364. 5 indexed citations
13.
Zhou, Ran, Yue‐Bei Luo, Qiuming Zeng, & Huan Yang. (2020). Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases. Frontiers in Immunology. 11. 1884–1884. 46 indexed citations
14.
Jiang, Fei, Huan Yang, Jing Li, et al.. (2020). Novel GALC Mutations Cause Adult-Onset Krabbe Disease With Myelopathy in Two Chinese Families: Case Reports and Literature Review. Frontiers in Neurology. 11. 830–830. 4 indexed citations
15.
Zeng, Qiuming, et al.. (2017). Cognitive impairment in Chinese IIDDs revealed by MoCA and P300. Multiple Sclerosis and Related Disorders. 16. 1–7. 9 indexed citations
16.
Ouyang, Song, Zhaohui Luo, Qiuming Zeng, et al.. (2017). Immature Exosomes Derived from MicroRNA-146a Overexpressing Dendritic Cells Act as Antigen-Specific Therapy for Myasthenia Gravis. Inflammation. 40(4). 1460–1473. 43 indexed citations
17.
Tang, Juan, Qiuming Zeng, Song Ouyang, et al.. (2017). HECT E3 Ubiquitin ligase Nedd4 is required for anti-fungal innate immune response. The Journal of Immunology. 198(Supplement_1). 70.5–70.5. 1 indexed citations
18.
Zeng, Qiuming, Xiaohua Dong, Bo Hu, et al.. (2016). CD14+CD16++ monocytes are increased in patients with NMO and are selectively suppressed by glucocorticoids therapy. Journal of Neuroimmunology. 300. 1–8. 17 indexed citations
19.
Xiao, Yun, Juan Tang, Hui Guo, et al.. (2016). Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. Nature Medicine. 22(8). 906–914. 71 indexed citations
20.
Liu, Xiaofang, Bo Hu, Qiuming Zeng, et al.. (2016). MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10. Clinical Immunology. 164. 106–113. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimitoshi Kimura Breakdown of academic impact, for papers by Truong‐Minh Dang Breakdown of academic impact, for papers by Na Yao Breakdown of academic impact, for papers by Ning‐Yuan Chen Breakdown of academic impact, for papers by Maria Stensland Breakdown of academic impact, for papers by Catherine Dowling Breakdown of academic impact, for papers by Amin Daei Sorkhabi Breakdown of academic impact, for papers by Maria Dobre Breakdown of academic impact, for papers by Sarah Williams Breakdown of academic impact, for papers by Chiara Baiguera
Rankless by CCL
2026